Rinvoq ER 30 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FWZAB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $50,037
Award facts
- Contract value 100% obligated
- $50,037.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of RINVOQ ER 30 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order has a ceiling value of $50,037.44 and an ultimate completion date of August 6, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's SPE2DX prime contract functions as a comprehensive global pharmaceutical support vehicle enabling the supply of diverse pharmaceutical products and medical supplies to support military healthcare programs worldwide. This delivery order for RINVOQ ER tablets—a JAK inhibitor used in the treatment of rheumatoid arthritis and other inflammatory conditions—reflects the company's ongoing role in supplying specialty medications and pharmaceutical products to the Defense Health Agency and related federal healthcare systems. No set-aside designation was used for this award.
Quick answers
Who was awarded contract SPE2DB25FWZAB?
SPE2DB25FWZAB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 5, 2025.
How much is contract SPE2DB25FWZAB worth?
The government has obligated $50,037 on SPE2DB25FWZAB.
Is contract SPE2DB25FWZAB an order under another contract?
Yes. SPE2DB25FWZAB is a delivery order under SPE2DB25D3012, an indefinite delivery contract.
Was contract SPE2DB25FWZAB competed?
The extent of competition for SPE2DB25FWZAB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award